chr2-73292155-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001965.4(EGR4):āc.763G>Cā(p.Val255Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000557 in 1,435,540 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V255G) has been classified as Likely benign.
Frequency
Consequence
NM_001965.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EGR4 | NM_001965.4 | c.763G>C | p.Val255Leu | missense_variant | 2/2 | ENST00000436467.4 | |
EGR4 | XM_047443603.1 | c.760G>C | p.Val254Leu | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EGR4 | ENST00000436467.4 | c.763G>C | p.Val255Leu | missense_variant | 2/2 | 1 | NM_001965.4 | P2 | |
EGR4 | ENST00000545030.1 | c.1072G>C | p.Val358Leu | missense_variant | 2/2 | 1 | A2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000507 AC: 1AN: 197298Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 106978
GnomAD4 exome AF: 0.00000557 AC: 8AN: 1435540Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 711890
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2022 | The c.1072G>C (p.V358L) alteration is located in exon 2 (coding exon 2) of the EGR4 gene. This alteration results from a G to C substitution at nucleotide position 1072, causing the valine (V) at amino acid position 358 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at